Related references
Note: Only part of the references are listed.Nucleolar protein B23 has molecular chaperone activities
Attila Szebeni et al.
PROTEIN SCIENCE (2010)
Rapid method for detection of mutations in the nucleophosmin gene in acute myeloid leukemia
Todd S. Laughlin et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia
M. P. Martelli et al.
LEUKEMIA (2008)
Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia:: recent advances
Krzysztof Mrozek et al.
CURRENT OPINION IN HEMATOLOGY (2007)
CD7 expression predicts poor disease free survival and post-remission survival in patients with acute myeloid leukemia and normal karyotype
Hong Chang et al.
LEUKEMIA RESEARCH (2007)
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia
Brunangelo Falini et al.
BLOOD (2006)
Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)
Christian Thiede et al.
BLOOD (2006)
Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML):: association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance
RGW Verhaak et al.
BLOOD (2005)
Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype
S Schnittger et al.
BLOOD (2005)
Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics:: interaction with other gene mutations
K Döhner et al.
BLOOD (2005)
Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia
T Suzuki et al.
BLOOD (2005)
Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication
W Wang et al.
NATURE CELL BIOLOGY (2005)
Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia
NI Noguera et al.
LEUKEMIA (2005)
B23 regulates GADD45a nuclear translocation and contributes to GADD45a-induced cell cycle G2-M arrest
H Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics
G Marcucci et al.
CURRENT OPINION IN HEMATOLOGY (2005)
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
B Falini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23
D Bertwistle et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CRI): an intention-to-treat analysis of the EORTC/GIMEMA AML-10 trial
S Suciu et al.
BLOOD (2003)
Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics:: a study of the AML Study Group Ulm
S Fröhling et al.
BLOOD (2002)
The role of nucleophosmin in centrosome duplication
M Okuda
ONCOGENE (2002)
Nucleophosmin regulates the stability and transcriptional activity of p53
E Colombo et al.
NATURE CELL BIOLOGY (2002)
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia:: association with FAB subtypes and identification of subgroups with poor prognosis
C Thiede et al.
BLOOD (2002)
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials
PD Kottaridis et al.
BLOOD (2001)
Share Paper
